Eil Lilly announces Zepbound to be sold directly to consumers

(4:4)

Eli Lilly: Becoming the world's biggest pharmaceutical company 1876-2024

(2:1econd)

David A Ricks, Chair and Chief Executive Officer of Eli Lilly and Company

(45:30)

Eli Lilly to sell Zepbound directly to consumers without insurance coverage

(3:14)

Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic

(7:14)

Eli Lilly sells cheaper Zepbound option to meet demand | REUTERS

(1:21)

Eli Lilly Chief Scientific Officer explains Zepbound's weight loss advantage

(4:49)

Eli Lilly's drop after earnings is a buying opportunity, says Mizuho's Jared Holz

(5:27)

Eli Lilly CEO: We have 11 pipeline projects in obesity

(2:22)

Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine

(30:33)

Why Work at Eli Lilly and Company?

(1:21)

Inside Lilly's Corporate Center

(3:40)

Eli Lilly to sell Zepbound directly to consumers without insurance

(3:)

Why Lilly

(3:19)

Eli Lilly’s Affordable Weight Loss Breakthrough

(36)

Exclusive: How Eli Lilly’s making weight loss drugs more accessible

(7:4)

Eli Lilly’s new Ozempic alternative

(44)